Sun Pharmaceutical Industries Ltd.

Financial

	Sun Pharma Inds.	Cipla	Torrent Pharma
Operational Metrics
API Sector
US DMF Filings	518.0 .	2204.0 .	n/a
US DMF Approval	397.0 .	n/a	n/a
Pharmaceutical Sector
Number of ANDA's Filed in USA	650.0 .	283.0 .	168.0 .
Number of ANDA's Approved By USFDA	541.0 .	204.0 .	132.0 .
Domestic Sales Growth - YoY	13.7 %	9.2 %	15.7 %
R&D as a % of Total Sales	6.3 %	5.1 %	5.4 %
Financials
5 yr Average ROE	10.31 %	12.48 %	20.0 %
5yr average Equity Multiplier	1.37	1.31	2.34
5yr Average Asset Turnover Ratio	0.55	0.78	0.65
5yr Avg Net Profit Margin	13.53 %	12.29 %	13.21 %
Price to Book	6.02	4.11	14.59
P/E	36.42	23.33	58.79
5yr Avg Cash Conversion Cycle	-31.93 Days	-4.58 Days	-189.03 Days
Inventory Days	60.94 Days	58.34 Days	54.5 Days
Days Receivable	85.38 Days	45.49 Days	41.38 Days
Days Payable	165.78 Days	110.05 Days	318.84 Days
5yr Average Interest Coverage Ratio	35.55	33.93	5.79
5yr Avg ROCE	16.04 %	17.45 %	23.72 %
5yr Avg Operating Profit Margin	24.95 %	21.56 %	29.52 %
5 yr average Debt to Equity	0.09	0.07	0.83
5yr CAGR Net Profit	20.53 %	21.66 %	10.08 %
5yr Average Return on Assets	7.59 %	9.64 %	8.58 %
Shareholdings
Promoter Holding	54.48 %	29.19 %	68.31 %
Share Pledged by Promoters	0.69 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-6.92 %	-2.94 %
Change in Mutual Fund Holding (3 Yrs)	0.44 %	7.31 %	-1.85 %

Business

	Sun Pharma Inds.	Cipla	Torrent Pharma
Product Wise Break-Up	Product Wise Break-Up US Formulations 33.0 India Branded Generics 32.0 Emerging Market 18.0 Western Europe & Other Markets 13.0 Active Pharmaceutical Ingredient (API) 4.0 New ventures 0 Pharmaceuticals 0 Domestic formulations 0 Contract Manf. 0 Brazil/Latam 0 Germany/Europe 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 New ventures 4.79 Pharmaceutical 95.21 Germany/Europe 0 Domestic formulations 0 Emerging Market 0 Brazil/Latam 0 Contract Manf. 0 US Formulations 0 Western Europe & Other Markets 0 India Branded Generics 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 New ventures 0 Pharmaceuticals 0 Germany 13.15 Domestic Formulations 42.15 Emerging Market 0 Brazil 8.98 Contract Manufacturing 6.15 US Formulations 20.71 Western Europe & Other Markets 0 India Branded Generics 0 Others 8.86
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 20.0 Cardiac Science 17.0 Gastro Intestinal 14.0 Anti - Diabetes 8.0 Pain Management 7.0 Anti-Infective 6.0 Respiratory Systems 5.0 Vitamins / Minerals / Nutrients 5.0 Gynecology 4.0 Dermatology 4.0 Ophthalmology 3.0 Urology 3.0 Anti-infectives 0 Cardiac 0 Gastro Intestinal 0 Antivirals 0 Derma 0 Neuro /CNS 0 Gynaec. 0 Vitamins 0 Antineoplast 0 Opthal/Otologicals 0 Oncology 0 Anti Diabetic 0 Others 4.0	Therapeutic Area Wise Break-Up - Domestic Cardiac Science 0 Anti-Infective 0 Anti - Diabetes 0 Antivirals 0 Anti - Diabetes 5.6 Gastro Intestinal 5.4 Ophthalmology 0 Central Nervous System (CNS) 0 Respiratory Systems 0 Vitamins / Minerals / Nutrients 0 Gynaec. 0 Ophthalmology 3.0 Derma 3.3 Central Nervous System (CNS) 3.3 Dermatology 0 Oncology 0 Vitamins 0 Anti-Infective 14.0 Antineoplast 0 Gynecology 0 Pain Management 0 Cardiac Science 11.4 Urology 4.7 Others 49.3	-
Location Wise Break-Up	Location Wise Break-Up USA 33.26 India 32.24 Emerging Market 19.35 Rest of the World 15.15 SAGA 0 Europe 0 Global API 0 North America 0 Germany 0 Brazil 0	Location Wise Break-Up Rest of the World 0 Global API 2.0 India 44.0 SAGA 14.0 Europe 12.0 Brazil 0 Emerging Market 0 Germany 0 USA 0 North America 27.0 Others 1.0	Location Wise Break-Up Rest of the World 0 Global API 0 India 56.28 SAGA 0 Europe 0 Brazil 10.36 Emerging Market 0 Germany 10.04 USA 9.65 North America 0 Others 13.67

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

SIGN UP FOR FREE